secukinumab
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract Background: Regarding treatment of psoriasis, dermatologists now use new, highly effective targeted therapies. Among…
A recent review by Hu et al. highlights the use of biologic switching in clinical practice to maximize skin clearance and improve…
Psoriasis is a systemic disease with numerous concomitant metabolic disorders. Apparently, T‐helper 17 lymphocytes and…
To evaluate efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis (AS) via a pooled subgroup…
Dear Editor, Oral lichen planus (OLP) is a chronic T-cell-mediated inflammatory disease of the oral mucosa. Although the…
Lupus patients are in need of modern drugs to treat specific manifestations of their disease effectively and safely. In the past…
BACKGROUND
Monoclonal antibodies that target both Interleukin (IL)-12 and IL-23 have shown great efficacy in the treatment of…
A Phase III trial for a first-in-class psoriasis drug provides encouraging data, but the emerging agents still have to prove…